Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · IEX Real-Time Price · USD
0.894
+0.004 (0.49%)
At close: Nov 28, 2023, 3:59 PM
0.860
-0.034 (-3.84%)
After-hours: Nov 28, 2023, 6:36 PM EST
Cardiol Therapeutics Stock Forecast
Stock Price Forecast
According to 2 stock analysts, the average 12-month stock price forecast for CRDL stock stock is $4.50, which predicts an increase of 403.19%. The lowest target is $3.00 and the highest is $6.00. On average, analysts rate CRDL stock stock as a strong buy.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 14, 2023.
Analyst Ratings
The average analyst rating for CRDL stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3 | Buy | Reiterates | $3 | +235.46% | Aug 14, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $5 → $6 | Strong Buy | Maintains | $5 → $6 | +570.92% | May 19, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 17, 2021 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 3, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.43
from -0.49
EPS Next Year
-0.36
from -0.43
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 17.7M | 126.4M |
| Avg | n/a | n/a | n/a | 5.7M | 56.1M |
| Low | n/a | n/a | n/a | n/a | 11.5M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | - | 2,108.2% |
| Avg | - | - | - | - | 880.4% |
| Low | - | - | - | - | 101.5% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -0.38 | -0.23 | -0.27 | -0.26 | 0.13 |
| Avg | -0.43 | -0.36 | -0.36 | -0.26 | 0.12 |
| Low | -0.48 | -0.55 | -0.54 | -0.25 | 0.12 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.